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Abstract
Background: Spindle assembly checkpoint components BubR1 and Sgo1 play a key role in the maintenance of
chromosomal instability during cell division. These proteins function to block the anaphase entry until all condensed
chromosomes have been attached by the microtubules emanating from both spindle poles. Haplo-insufficiency of
either BubR1 or SGO1 results in enhanced chromosomal instability and tumor development in the intestine. Recent
studies show that spindle checkpoint proteins also have a role in slowing down the ageing process. Therefore, we
want to study whether haplo-insufficiency of both BubR1 and SGO1 accelerates cellular senescence in mice.
Methods: We took advantage of the availability of BubR1 and SGO1 knockout mice and generated primary murine
embryonic fibroblasts (MEFs) with mutations in either BubR1, SGO1, or both and analyzed cellular senescence of the
MEFs of various genetic backgrounds.
Results: We observed that BubR1+/−SGO+/− MEFs had an accelerated cellular senescence characterized by morphological
changes and expressed senescence-associated β-galactosidase. In addition, compared with wild-type MEFs or MEFs with
a single gene deficiency, BubR1+/−SGO1+/− MEFs expressed enhanced levels of p21 but not p16.
Conclusions: Taken together, our observations suggest that combined deficiency of BubR1 and Sgo1 accelerates cellular
senescence.
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Background
Senescent cells are characterized as having gradually lost
the ability to divide. Senescence is the main risk factor
for age-related disorders including diabetes, atheroscler-
osis, hypertension, osteoarthritis, and Alzheimer’s dis-
ease and Parkinson’s disease [1]. There are two types of
senescence including replicative senescence and prema-
ture senescence. The replicative senescence is driven
largely by telomere shortening [2], whereas the prema-
ture senescence is characterized by permanent cell cycle
arrest without telomere deterioration [3]. Senescence
can be induced by a variety of stressors including UV,
oxidative stress, genomic instability, free radical accumu-
lation, and inflammatory cytokines. Senescent cells are
characterized by an increased cell size and expression of
senescence-associated β-galactosidase (SA-β-Gal). In
addition, senescent cells undergo permanent cell cycle
arrest, which is accompanied by expressing enhanced
levels of negative regulators for cell division including
p21, p16, and PTEN.
Spindle checkpoint proteins play a key role in the
maintenance of chromosomal instability during cell div-
ision [4]. BubR1 is one of spindle checkpoint proteins
which functions to block the anaphase entry until all
chromosomes have been attached by the microtubules
emanating from both spindle poles. Homozygous dele-
tion of BubR1 results in embryonic lethality [5]. BubR1
haplo-insufficiency (BubR1+/−) causes enhanced chromo-
somal instability and tumorigenesis [6]. Extensive re-
search in the past has shown that BubR1-deficient mice
also exhibit age-related phenotypes including short life-
span, cachectic dwarfism, lordokyphosis, cataracts, and
impaired wound healing [7, 8]. In contrast, increased ex-
pression of BubR1 extends healthy lifespan in a mouse
model [9]. Therefore, spindle checkpoint protein BubR1
plays an important role in suppressing ageing.
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Shugoshin 1 (Sgo1) functions to maintain sister chro-
matid cohesion, preventing premature cleavage of the
cohesin complex by separase [10, 11]. Cells with Sgo1
depletion experience difficulty in completing chromo-
some congression, leading to accumulation of clusters of
chromosomes that surround the spindle poles [12–14].
In the absence of Sgo1, the metaphase plate collapses
prior to completion of congression of all chromosome
pairs [12]. Missegregation of sister chromatids induced
by Sgo1 depletion appears to be responsible for dramatic
mitotic arrest [15]. A splice variant of Sgo1 is also in-
volved in the maintenance of centriole cohesion [15, 16].
Similar to many spindle checkpoint proteins, haplo-
insufficiency of SGO1 also predisposes mice to the de-
velopment of malignancies [10].
Given the availability of BubR1 and SGO1 heterozy-
gous mice, we generated primary murine embryonic fi-
broblasts (MEFs) with mutations in either BuBR1,
SGO1, or both. We studied whether deficiency in the
checkpoint gene(s) had an impact on cellular senes-
cence. We observed that BubR1+/− and SGO+/− MEFs
had an accelerated cellular senescence characterized by
the morphological changes and expression of SA-β-Gal.
Moreover, double mutant MEFs (BubR1+/−SGO1+/−) ex-
hibited the highest rate of cellular senescence, which
was accompanied by early appearance of morphological
changes and expression of SA-β-Gal. Compared with
wild-type MEFs or MEFs with a single gene deficiency,
BubR1+/−SGO1+/− MEFs expressed elevated levels of p21
but not p16.
Methods
Mouse colonies and MEFs
Transgenic knockout mice (BubR1+/− mice and SGO1+/−
mice) were maintained at the animal facility of New
York University Langone Medical Center. The mainten-
ance was fully compliant with the general guidelines out-
lined by the United States Department of Agriculture
and the American Association of Laboratory Animal
Care under the supervision and specific approval of the
Institutional Animal Care and Use Committees. BubR1
+/−SGO1+/− compound mutant mice were obtained by
crossing BubR1+/− mice with SGO1+/− mice. Primary
MEFs of various genotypes were obtained from embryos
(embryonic day 14.5) of mice of BubR1+/− and SGO1+/−
crossing. MEF cells were cultured at 37 °C under 5 %
CO2 in 100-mm plates containing Dulbecco minimum
essential medium (DMEM) supplemented with 10 %
fetal bovine serum (FBS) and antibiotics (100 μg/ml of
penicillin and 50 μg/ml of streptomycin sulfate; Invitro-
gen). Serial cultures were carried out in which cells were
trypsinized and replated at a density of 106 cells/100-mm
dish every 7 days.
Genotyping
Genotyping was carried out as previously described
[5, 10]. Briefly, genomic DNA was purified from
mouse tail or MEFs. The PCR for detecting BubR1
genotype was carried out with PCR primers as fol-
lows: the forward primer A of 5′GGG AGG ATC
GAG GAG GTC G3′, the forward primer long-
terminal repeat 2 (LTR2) of 5′AAA TGG CGT TAC
TTA AGC TAG CTT GC3′, and the reverse primer
B of 5′CTG TTC GCC TTC AGT GCT CAA AAT
GGT AGT CG3′. The reaction conditions included an
initial denaturation at 94 °C for 5 min followed by
35 cycles of 94 °C for 30 s, 58 °C for 30 s, and 72 °C
for 1 min. The final extension of the reactions was
set at 72 °C for 7 min. The PCR for SGO1 genotyping
was carried out with primers as follows: the forward
primer of 5′GAA AAG TAA GTC TGC TTA TGG
CTC A3′, the reverse primer of 5′CAG GTG TTG
TAG AAT AAT CCA AGC3′, and the reverse primer
long-terminal repeat (LTR) of 5′ATA AAC CCT CTT
GCA GTT GCA TC3′. The reaction conditions in-
cluded an initial denaturation at 94 °C for 3 min
followed by 35 cycles of 94 °C for 45 s, 57 °C for
45 s, and 72 °C for 1 min. The final extension was
set at 72 °C for 10 min. PCR products were analyzed
by electrophoresis on 2 % agarose gels and detected
by ethidium bromide staining.
Senescence-associated β-galactosidase staining
MEF cells were seeded at a density of 3 × 104 cells (at
passages 3 and 4), 4 × 104 cells (at passage 5), 5 × 104
cells (at passage 6), 6 × 104 cells (at passage 7), and 7 ×
104 cells (at passage 8) per well, respectively, on 12-well
plates. One day after seeding, MEFs were stained for SA-
β-Gal activity according to the manufacturer’s protocol
(Cell Signaling Technology). The percentage of senes-
cent cells was the total number of senescent cells divided
by the total number of cells counted under a light
microscope.
Western blot analysis
Western blot analysis was carried out as previously
described [17, 18]. Total MEF cell lysates were prepared in
the RIPA lysis buffer (50 mM Tris-HCl (pH 8.0), 150 mM
NaCl, 1 % NP-40, 0.1 % SDS, and 0.5 % sodium deoxycho-
late) supplemented with a mixture of protease and phos-
phatase inhibitors. Protein concentrations were measured
using the bicinchoninic acid protein assay (Pierce™ BCA
Protein Assay Kit, ThermoFisher Scientific). Equal amounts
of protein lysates from various samples were used for SDS–
PAGE analysis followed by immunoblotting. Luminata
Forte Western HRP substrate (Millipore) was used for
chemiluminescent detection.
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Statistical analysis
Statistical analysis and graphs were generated using the
Prism 6 (Graphpad). Data were analyzed for significant
differences using the two-tailed, independent t test with
Welch’s correction for un-equal variances, or with the
Mann-Whitney U test. A p value <0.05 was considered
statistically significant.
Results and discussion
It is well documented that deficiency in spindle check-
point control results in chromosomal instability, aneu-
ploidy, and tumorigenesis [19–21]. Recent studies have
revealed that aneuploidy due to a weakened spindle
checkpoint accelerates ageing [7]. For example, mice
carrying hypomorphic BubR1 alleles develop a series of
ageing-related pathologies that include shortened life
span, growth retardation, fat loss, and impaired wound
healing [7]. Given that SGO1 also plays a role in the
maintenance of chromosomal stability during cell div-
ision and that it remains unclear whether SGO1-defi-
ciency also contributes to the accelerated ageing process,
we first obtained primary MEFs that were either haplo-
insufficiency of BubR1, SGO1, or both. Morphological
examination revealed that SGO1-deficient MEFs ap-
peared to be similar to that of BubR1-deficient ones,
which grew at a slightly faster rate than the wild-type
MEFs (data not shown). However, compound mutant
MEFs (BubR1+/−SGO1+/−) grew at a much slower rate,
and a small fraction of these cells exhibited morpholo-
gies of senescent cells at early passages (e.g., P4) (Fig. 1).
Many MEFs became large, flat, and/or multinucleated.
With each passage, these morphologically distinct cells sig-
nificantly increased in BubR1+/−SGO1+/− MEFs compared
with wild-type MEFs. By passage 8, a high fraction of
BubR1+/−SGO1+/− displayed senescent cell morphologies.
These senescent-like cells were also present in BubR1- and
SGO1-deficient cells at late passage (passage 8).
Given that lysosomal SA-β-Gal is a reliable and widely
used biomarker for senescent cells, we stained MEFs of
various genotypes for SA-β-Gal expression. We observed
that a significant number of BubR1+/−SGO1+/− MEFs at
very early passages (e.g., passage 3) already expressed
SA-β-Gal where few, if any, wild-type MEFs expressed
this enzyme (Fig. 2). Some MEFs with a single gene defi-
ciency (BubR1+/− or SGO1+/−) also expressed SA-β-Gal,
indicative of their senescent status. However, MEFs with
compound mutations displayed a much higher tendency
toward senescence. At passage 6, a significant number of
BubR1+/− or SGO1+/− MEFs also expressed SA-β-Gal
(Fig. 3). However, BubR1+/−SGO1+/− MEFs expressed
SA-β-Gal at a higher level, evidenced by the stronger
signals of SA-β-Gal than MEFs with a single gene
deficiency.
We then systematically analyzed SA-β-Gal expression in
MEFs of various genotypes at different passages. We ob-
served that a small fraction (around 3 %) of wild-type
MEFs started to express SA-β-Gal at passage 4, and there
was gradual increase in the percentage of SA-β-Gal-posi-
tive cells (Fig. 4). On the other hand, BubR1+/− MEFs ex-
hibited a significant increase of SA-β-Gal-positive cells
Fig. 1 BubR1+/−SGO1+/− MEFs exhibit senescent-like morphologies at an accelerated rate. Primary MEFs of various genetic backgrounds (wild-type,
BubR1+/−, SGO1+/−, and BubR1+/−SGO1+/−) were cultured in DMEM supplemented with FBS and antibiotics as described in the Methods section.
Serial cultures were carried out at a density of 106 cells/100-mm dish every 7 days. At each passage, images of MEFs were recorded with a light
microscope. Images of MEFs of wild-type (WT), BubR1+/−, SGO1+/−, and BubR1+/−SGO1+/− at passages 4, 6, and 8 are shown
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Fig. 2 BubR1+/− or SGO1+/− deficiency leads to enhanced expression of β-galactosidase. Primary MEFs of various genetic backgrounds (wild-type,
BubR1+/−, SGO1+/−, and BubR1+/−SGO1+/−) at passage 6 were stained for senescence-associated β-Gal activity (blue according to the manufacturer’s
protocol. β-Gal-positive cells were stained with blue
Fig. 3 BubR1+/−SGO1+/− MEFs express SA-β-Gal much earlier than
wild-type BubR1+/− or SGO1+/− MEFs. a Primary MEFs of various genetic
backgrounds (wild-type and BubR1+/−SGO1+/−) at passage 3 were stained
for senescence-associated β-Gal activity. b Primary MEFs of various genetic
backgrounds (wild-type BubR1+/−, SGO1+/−, and BubR1+/−SGO1+/−) at
passage 3 were stained for senescence-associated β-Gal activity. β-Gal-
positive cells were recorded. Summarized data from three independent
experiments are shown
Fig. 4 BubR1+/−SGO1+/− compound mutations accelerate
senescence. Primary MEFs of various genetic backgrounds (wild-type,
BubR1+/−, SGO1+/−, and BubR1+/−SGO1+/−) were cultured in DMEM as
described in the Methods section. MEFs of different passages were
stained for SA-β-Gal. Percents of SA-β-Gal cells were recorded. Data
summarized from three independent experiments are presented
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around passage 5, reaching the peak level at passage 6.
Slightly different from BubR1+/− MEFs, SGO1+/− MEFs
showed a significant increase in the percentage of SA-β-
Gal-positive cells at passage 4, reaching the peak level at
passage 7. The percentage of SA-β-Gal-positive cells in
SGO1+/− MEFs was higher than that in BubR1+/− MEFs.
Moreover, in addition to early (passage 3) display of cellu-
lar senescence, BubR1+/−SGO1+/− MEFs also had a higher
percentage of cells positive for SA-β-Gal at passages 4 and
5. It appears that the highest percentage of SA-β-Gal-posi-
tive cells in all genotypes was around 37 %. Thus, there is
a synergy of premature ageing between reduced expres-
sion of BubR1 and SGO1.
To further confirm accelerated ageing due to the re-
duced expression of spindle checkpoint genes, we ana-
lyzed several molecular markers including p21 and p16
that are frequently linked to cellular senescence. At pas-
sage 3, BubR1+/−SGO1+/− MEFs had a high level of p21
expression compared with that of BubR1+/− or SGO1+/−
MEFs (Fig. 5). Expression of p21 further increased with
additional passages, which was roughly correlated with
percentages of SA-β-Gal-positive cells. On the other
hand, there was little difference of p16 expression
among early passages until passages 7 and 8 in BubR1
+/−SGO1+/− MEFs. Moreover, there was no significant
difference of p16 expression between BubR1 (or SGO1)-
deficient and BubR1 (or SGO1)-competent MEFs. These
observations suggest that p16 expression may not be re-
sponsible for the observed cellular senescence in MEFs
that are haplo-insufficiency of BubR1, SGO1, or both.
In this study, we systematically analyzed cellular senes-
cence in cells deficient in BubR1 and/or Sgo1. It is
known that reduced expression of BubR1 induces pre-
mature ageing which is associated with enhanced cellu-
lar senescence [7]. We have shown for the first time that
haplo-insufficiency of SGO1 also causes increased senes-
cence. Sgo1 appears to play a more important role in
suppressing ageing as haplo-insufficiency of SGO1 in-
duces cellular senescence earlier and to a greater extent
than haplo-insufficiency of BubR1. At the molecular
level, BubR1 and Sgo1 function differently in suppress-
ing premature separation of sister chromatids [20].
BubR1 is an integral component of the spindle check-
point by suppressing the activity of APC/C [22, 23],
whereas Sgo1 is physically associated with cohesin, pre-
venting its premature cleavage by separase. Therefore, it
is reasonable to predict that there is a synergy between
BubR1 and Sgo1 in suppressing premature sister chro-
matid separation and chromosomal instability in cell div-
ision. Consistent with this prediction, we have observed
that reduced expression of both BubR1 and Sgo1 results
in accelerated cellular senescence.
We have shown that enhanced senescence is corre-
lated with elevated expression of p21 but not p16. As it
is well known that cellular senescence is associated with
permanent cell cycle arrest, it is logical that expression
of CDK inhibitors such as p21 is significantly elevated.
Although we did not observe that p16 expression is high
in MEFs that are undergoing senescence, we cannot ex-
clude the possibility that expression of other inhibitors
of the INK family including p15, p17, or p19 is elevated.
Although they all function to block cell cycle progres-
sion, p21 and p16 act differently in the negative regula-
tion of CDKs. As a member of the INK family, p16
solely acts as an inhibitor that blocks G1 CDKs (CDK4/
6). On the other hand, p21 is capable of inhibiting CDKs
of several cell cycle transitions including S and G2/M.
Given that BubR1 and Sgo1 have primary functions in
mitosis, it is logical to speculate that impaired functions
of these checkpoint components can trigger cell cycle
arrest and senescence by activating p21 expression.
Conclusions
This study is consistent with the notion that chromo-
somal instability due to reduced expression of spindle
assembly checkpoint components contributes to age-
ing processes. The combined deficiency of BubR1 and
SGO1 accelerates cellular senescence which is mani-
fested as morphological changes and enhanced ex-
pression of SA-β-Gal.
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Fig. 5 a BubR1+/−SGO1+/− MEFs express enhanced levels of p21. MEFs
of various genetic backgrounds (wildtype, BubR1+/−, SGO1+/−, and
BubR1+/−SGO1+/−) were cultured and passed in vitro as described in
the Methods section. MEFs of different passages were collected and
lysed. Equal amounts of cell lysates were blotted for p21 and β-actin.
b The same set of lysates were blotted with antibody to p16
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